Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3754]

Double-agent chemotherapy gives survival benefit to patients over 70 with lung cancer; thus current monotherapy-only strategy should be revised

Double-agent chemotherapy gives survival benefit to patients over 70 with lung cancer; thus current monotherapy...

New molecule tested as a delivery vehicle to image and kill brain tumours

New molecule tested as a delivery vehicle to image and kill brain tumours

Landmark ovarian cancer discover as scientists unveil high risk gene

Landmark ovarian cancer discover as scientists unveil high risk gene

Neoadjuvant chemoradiotherapy and radiotherapy deliver survival benefit in oesophageal cancer

Neoadjuvant chemoradiotherapy and radiotherapy deliver survival benefit in oesophageal cancer

JQ1 shows potential as treatment for AML

JQ1 shows potential as treatment for AML

New imaging new technique uses vitamin C to detect more aggressive tumours

New imaging new technique uses vitamin C to detect more aggressive tumours

New ASCO guidelines on chemotherapy and resistance assays

New ASCO guidelines on chemotherapy and resistance assays

NICE: final guidance recommends bortezomib and thalidomide in multiple myleoma

NICE: final guidance recommends bortezomib and thalidomide in multiple myleoma

New protein structure model to inhibit cancer

New protein structure model to inhibit cancer

5 years of tamoxifen improves 15-year survival by about a third in women with most common type of breast cancer

5 years of tamoxifen improves 15-year survival by about a third in women with most common type of breast cancer

More from ecancer